ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,331Medicare Part D Prescriptions Filled, Including Refills

Rank: 53 out of 252

$692K Total Retail Price of All Prescriptions

Rank: 52 out of 252

451 Patients Receiving at Least One Drug in Part D
62%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 451 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 451 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

5% of this provider’s 7,919 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 564 219 S3 1 5
AMLODIPINE BESYLATE 462 290 2 4
LISINOPRIL 450 267 3 3
SIMVASTATIN 411 314 4 2
OMEPRAZOLE 409 206 5 6
POTASSIUM CHLORIDE 399 253 6 8
LEVOTHYROXINE SODIUM 346 246 7 1
HYDROCHLOROTHIAZIDE 294 184 8 13
GUANFACINE HCL 279 117 R 10 9 166
TRIAMTERENE-HCTZ 275 150 10 33
METFORMIN HCL 243 153 11 9
METOPROLOL TARTRATE 240 155 12 10
LOSARTAN POTASSIUM 231 167 13 24
ZOLPIDEM TARTRATE 222 94 14 21
FUROSEMIDE 213 146 15 7
CRESTOR 177 113 16 34
AMITRIPTYLINE HCL 171 119 R 17 46
LOVASTATIN 170 102 18 39
CITALOPRAM HBR 169 91 19 15
TAMSULOSIN HCL 166 83 20 26
METOPROLOL SUCCINATE 158 126 21 19
ATENOLOL 152 103 22 18
FLUTICASONE PROPIONATE 152 78 22 36
ALENDRONATE SODIUM 149 138 24 32
ATORVASTATIN CALCIUM 148 107 25 16
NEXIUM 145 75 26 23
TRAMADOL HCL 143 83 27 17
PRAVASTATIN SODIUM 136 86 28 12
GABAPENTIN 130 39 29 11
WARFARIN SODIUM 129 109 30 14
DIOVAN 120 92 31 38
ALLOPURINOL 119 82 32 30
METFORMIN HCL ER 106 70 33 74
LYRICA 101 44 34 66
GLIPIZIDE ER 99 71 35 90
GLIPIZIDE 91 72 36 52
OXYCODONE HCL 89 24 S2 37 89
CYCLOBENZAPRINE HCL 88 0 R 38 51
CYMBALTA 83 46 39 45
PROMETHAZINE HCL 77 0 R 40 85
SYNTHROID 76 68 41 47
SPIRONOLACTONE 75 39 42 53
RANITIDINE HCL 70 20 43 48
CARVEDILOL 70 59 43 22
VENTOLIN HFA 67 31 45 102
TRAZODONE HCL 65 43 46 31
DIGOXIN 63 38 47 44
ADVAIR DISKUS 63 39 47 63
LANTUS 62 22 49 55
PROAIR HFA 61 28 50 54
NIFEDIPINE ER 61 42 50 108
FLUOXETINE HCL 58 38 52 57
AZITHROMYCIN 57 28 53 37
CARISOPRODOL 56 0 R 54 70
JANUVIA 55 43 55 88
COMBIVENT 55 24 55 123
MELOXICAM 54 40 57 20
FOSINOPRIL SODIUM 52 52 58 182
SERTRALINE HCL 51 31 59 27
FAMOTIDINE 51 33 59 59
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 15, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.